1.Effectiveness of a brief intervention for smoking cessation using the 5A model with self-help materials and using self-help materials alone: A randomised controlled trial
Maurice Steve Utap ; Christina Phoay Lay Tan ; Anselm Su Ting
Malaysian Family Physician 2019;14(2):2-9
Introduction: The ‘5A’ model for smoking cessation was introduced in 2000 by the US Department
of Health and Services. This brief intervention was recommended worldwide for smoking cessation.
However, little is known about its effectiveness for smoking cessation in a primary care setting in
Malaysia.
Objective: To determine the effectiveness of a brief intervention for smoking cessation using the ‘5A’
model with self-help materials compared to using self-help materials alone.
Methods: This randomised controlled trial was conducted at the Primary Care Clinic at the University
Malaya Medical Centre (UMMC) between June and October 2009. Subjects were all current smokers
aged 18 years and above. A total of 208 subjects were recruited and randomised into two groups.
Subjects in the intervention group were given a brief intervention based on the ‘5A’ model with selfhelp materials, while the control group received self-help materials alone. Subjects were later followed
up at one and four months via telephone calls. The outcome measure was a self-reported attempt to
quit smoking.
Results: At one-month follow-up, 15/77 (19.5%) of the participants in the intervention group had
attempted to quit smoking compared to 8/80 (10.0%) in the control group. There was no significant
difference between the two groups (p=0.09). At the four-month follow-up, 13/58 (22.4%) participants
in the intervention group had attempted to quit smoking compared to 9/57 (15.8%) in the control
group. Once more, there was no significant difference between the two groups (p=0.37).
Conclusion: This study showed that there was no significant difference between a brief intervention
using the ‘5A’ model with self-help materials and using self-help materials alone for smoking cessation
in a Malaysian primary care setting. However, these results do need to be treated with caution when
taking into consideration the high dropout rate and bias in the study design.
2.The effectiveness of diabetes medication therapy adherence clinic to improve glycaemic control among patients with type 2 diabetes mellitus: a randomised controlled trial
The Medical Journal of Malaysia 2020;75(3):246-253
Introduction: In Malaysia, Diabetes Medication Therapy
Adherence Clinic (DMTAC) in hospital settings significantly
improved patients' glycaemic control and cardiovascular
risk. Until now no randomised controlled trial of DMTAC has
been done in a primary care setting where the access to
subspecialist services (endocrinologists, expensive
medication, etc.) is limited. The objective of this research is
to compare the glycaemic control among diabetes mellitus
(DM) patients between those received additional DMTAC
service and those received normal clinic service in primary
care settings.
Materials and Method: This was a parallel, randomised
controlled study. The selected participants were patients
aged 18 to 70 years with type 2 DM on diabetic medication
who were being treated in Kota Samarahan Health Clinic
with HbA1c above 8% and who never attended any
education of DM prior to the study. The control group
received normal clinic visits with consultations by a medical
officer. The intervention group received four or more DMTAC
visits in addition to normal clinic visits. The primary
outcomes were HbA1c while the secondary outcomes were
the occurrence of severe hypoglycaemia, weight gain and
medication compliance of patients. The subjects were
randomised by numbered envelope opened chronologically
by the investigator during the initial assessment. All health
care professionals (nurse, lab staff and medical officer)
except DMTAC pharmacist managing the subjects were
blinded as there were no markings on the patients notes
indicating that they were in this study. The demographic
data was collected during screening while health data
including glycated haemoglobin (HbA1c) levels were
collected at baseline, sixth month and one year.
Results: In all, 100 patients were randomised into control
and intervention groups (n=50 per arm). The change of
HbA1c in the intervention group (mean=-1.58) was
significantly more than the control group (mean=-0.48) at 12
months with a mean difference of -1.10% (p=0.005, Cohen's
d=0.627). Both study groups had similar significant changes
of subjects from non-compliance to compliance (control
group, n=11 vs. intervention group, n=10). The changes of
BMI after 12 months between control group (0.24 kg/m2
) and
intervention group (0.24 kg/m2
) was not significant (p=0.910).
There were no episodes of severe hypoglycaemia detected
in both groups.
Conclusion: The addition of DMTAC service in primary care
can improve glycaemic control among patients.
The study was registered in the National Medical Research
Register (Malaysia): NMRR-13-1449-18955
FUNDING: This research received no specific grant from any
funding agency in the public, commercial, or not-for-profit
sectors. All blood test was done in our setting.
3.Reference interval establishment of full blood count extended research parameters in the multi-ethnic population of Malaysia
Angeli Ambayya ; Andrew Octavian Sasmita ; Qian Yun Zhang ; Anselm Su Ting ; Chang Kian Meng ; Jameela Sathar ; Subramanian Yegappan
The Medical Journal of Malaysia 2019;74(6):534-536
Haematological cellular structures may be elucidated using
automated full blood count (FBC) analysers such as Unicel
DxH 800 via cell population data (CPD) analysis. The CPD
values are generated by calculating volume, conductivity,
and five types of scatter angles of individual cells which
would form clusters or populations. This study considered
126 CPD parameter values of 1077 healthy Malaysian adults
to develop reference intervals for each CPD parameter. The
utility of the CPD reference interval established may range
from understanding the normal haematological cellular
structures to analysis of distinct cellular features related to
the development of haematological disorders and
malignancies.